Core Laboratories (NYSE:CLB) declared a quarterly dividend on Tuesday, October 9th, NASDAQ reports. Stockholders of record on Friday, October 19th will be paid a dividend of 0.55 per share by the oil and gas company on Tuesday, November 20th. This represents a $2.20 annualized dividend and a dividend yield of 2.05%. The ex-dividend date is Thursday, October 18th.

Core Laboratories has increased its dividend by an average of 3.2% annually over the last three years. Core Laboratories has a dividend payout ratio of 90.2% indicating that its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline. Research analysts expect Core Laboratories to earn $3.05 per share next year, which means the company should continue to be able to cover its $2.20 annual dividend with an expected future payout ratio of 72.1%.

Shares of Core Laboratories stock opened at $107.25 on Friday. The firm has a market cap of $5.12 billion, a PE ratio of 53.63, a price-to-earnings-growth ratio of 3.96 and a beta of 1.46. Core Laboratories has a 1-year low of $87.66 and a 1-year high of $130.34. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.85 and a current ratio of 2.24.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, July 25th. The oil and gas company reported $0.59 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.59. The business had revenue of $175.48 million for the quarter, compared to analysts’ expectations of $174.47 million. Core Laboratories had a net margin of 13.32% and a return on equity of 64.13%. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.51 EPS. As a group, equities analysts expect that Core Laboratories will post 2.44 EPS for the current fiscal year.

A number of brokerages recently issued reports on CLB. Zacks Investment Research raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Friday. ValuEngine raised shares of Core Laboratories from a “hold” rating to a “buy” rating in a report on Tuesday, September 4th. Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and set a $117.00 price target on the stock in a report on Monday, August 13th. Piper Jaffray Companies reissued a “hold” rating and set a $96.00 price target on shares of Core Laboratories in a report on Friday, July 27th. Finally, ABN Amro downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Monday, July 2nd. Two analysts have rated the stock with a sell rating, nine have given a hold rating and six have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $115.15.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

Read More: Tariff

Dividend History for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.